Nathan Coates

Experience

• 

  Charles River Laboratories

  May 2001 - Jul 2005

  • Technical Writer

    Jun 2004 - Jul 2005

  • Senior Technologist

    Jan 2003 - Jun 2004

  • Technologist

    May 2001 - Jan 2003
• 

  Vertex Pharmaceuticals

  Jul 2005 - now

  -Provide program management for international strategy groups on disease areas-Serve as global program manager for a pipeline disease area-Provide program management for buildout of international Development functions-Build and sustain international center of excellence for project management across multiple functions -Provided portfolio management of the multiple disease areas, including developing portfolio plan, contributing to disease area strategy, facilitating disease strategy team meetings, and tracking individual programs-Managed drug development programs in late development/commercial stage assets.-Developed portfolio-level deliverables for corporate planning, including timelines and assumptions for stage gating, long range planning, for R&D prioritization and resourcing decisions -Managed programs in research, development, and commercial stages-Provided portfolio management of a development-stage disease area, including coordinating strategic team meetings and agendas, tracking programs, and facilitating compilation of presentations for executive management-Developed portfolio-level deliverables for corporate planning, including timelines and assumptions for long range planning, for R&D prioritization and resourcing decisions -Provided integrated project management of drug research and development programs spanning the drug discovery and development lifecycle from early lead optimization through late development-Developed portfolio-level deliverables for corporate planning, including timelines and assumptions for long range planning, for R&D prioritization and resourcing decisions-Developed user requirements for SharePoint template used by internal R&D program teams throughout the company Provided integrated project management of drug research and development programs from late HTL/early lead optimization through early development Led regulatory compliance audits of GCP (Phase 1 unit, clinical labs) and GLP (tox labs) CROs, GMP CMOs (API, DP, and P&L manufacturing), clincial investigator sites, and internal GxP activities.

  • Senior Director, Chief of Staff International

    May 2022 - now

  • Senior Director, Program & Portfolio Management

    Jan 2020 - May 2022

  • Director, Program and Portfolio Management

    Feb 2016 - Dec 2019

  • Associate Director, R&D Program Management

    Aug 2014 - Feb 2016

  • Sr. Program Manager, R&D Program Management

    Oct 2011 - Aug 2014

  • Project Manager, R&D Program Management

    May 2010 - Oct 2011

  • Senior QA Specialist, Quality Partnership Management

    Mar 2008 - Apr 2010

  • QA Specialist, Quality Partnership Management

    Oct 2005 - Mar 2008

  • Research Document Specialist

    Jul 2005 - Oct 2005